Infectious Diseases News and Research

RSS

Rising temperatures may boost number of cases of Lyme disease, finds study

Lyme disease is the most common tick-borne disease in North America and its incidence has risen sharply in the last decade.

1 Nov 2018

University of Missouri receives NIH grant for continued operation of NSRRC

The University of Missouri has received $7.229 million for continued operation of the National Swine Resource and Research Center.

31 Oct 2018

Scientists pinpoint TIM-3 protein as next potential target for immunotherapy treatments

Following the 2018 Nobel Prize for Medicine, global attention is now more than ever turned toward the promise of immunotherapy in oncology. An international team’s work has shed new light on a molecule called TIM-3 that might play a key role in the regulation of the immune response.

31 Oct 2018

Research reveals high stability of hepatitis B viruses

At room temperature, hepatitis B viruses (HBV) remain contagious for several weeks and they are even able to withstand temperatures of four degrees centigrade over the span of nine months.

30 Oct 2018

New resource outlines neurologic effects and treatment options for biologic, chemical attacks

The neurologic effects and treatment options for exposure to biologic and chemical agents are outlined in a newly published article by neurologists from the University of Colorado School of Medicine who collaborated on the article with military physicians.

26 Oct 2018

The Lancet Infectious Diseases journal publishes clinical trial results for Shionogi’s cefiderocol

Shionogi & Co., Ltd. announced today that The Lancet Infectious Diseases journal has published clinical results from the pivotal randomized controlled trial evaluating cefiderocol for the treatment of complicated urinary tract infection in patients at risk of multidrug-resistant Gram-negative infections.

26 Oct 2018

Scientists determine normal function of gene associated with ALS and FTD

The normal function of a gene associated with the neurodegenerative diseases amyotrophic lateral sclerosis and frontotemporal dementia has been determined for the first time by University of Bath scientists.

24 Oct 2018

High-dose influenza vaccine associated fewer hospitalizations in dialysis patients

Results from a new study suggest that high-dose influenza vaccine is associated with lower risk for hospitalizations in kidney failure patients on dialysis. The findings appear in an upcoming issue of the Clinical Journal of the American Society of Nephrology

24 Oct 2018

HPTN 075 study shows high risk of HIV infection among MSM and TGW in sub-Saharan Africa

Researchers from the HIV Prevention Trials Network today presented results from the HPTN 075 Study at the HIV Research for Prevention conference in Madrid, Spain.

24 Oct 2018

Emergex completes toxicology testing on gold nanoparticle carrier system for vaccine platform

Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, today announces the successful completion of preclinical toxicology testing on the gold nanoparticle carrier system that forms the fundamental basis for Emergex's entire infectious disease vaccine platform.

24 Oct 2018

Temperature increases in Zambezi Valley may cause major declines in tsetse populations

A new study, based on 27 years of data from Mana Pools National Park in Zimbabwe, suggests that temperature increases over the last three decades have already caused major declines in local populations of tsetse flies.

24 Oct 2018

Simple technology prevents infectious disease outbreaks in low-resource settings

A pilot study in which healthcare workers in the Central African Republic used a smartphone app to transmit public health disease reports to health authorities demonstrates that this technique contributes to early detection and prevention of infectious diseases and outbreaks.

24 Oct 2018

Gut bacterial community of healthy adults recovers after short-term exposure to broad-spectrum antibiotics

The trillions of bacteria in the human gut affect our health in multiple ways including effects on immune functions and metabolism.

23 Oct 2018

New diagnostic platform simultaneously screens for all known pathogenic bacteria

Scientists at the Center for Infection and Immunity in the Columbia University Mailman School of Public Health have developed the first diagnostic platform that can simultaneously screen for all known human pathogenic bacteria as well as markers for virulence and antibiotic resistance.

23 Oct 2018

Scientists develop new class of compounds for treatment of progressive neurodegenerative disorder

St. Jude Children's Research Hospital investigators have developed a new class of compounds that extended the lives and eased symptoms of mice with a progressive neurodegenerative human disorder.

23 Oct 2018

Map of human liver cells reveals molecular make-up of individual cells

A map of the cells in the human liver has been created by University Health Network Transplant Program and University of Toronto researchers, revealing for the first time differences between individual cells at the molecular level which can have a profound impact on their behaviour in tissue, tumours and disease.

From 10x Genomics, Inc. 23 Oct 2018

SLU researcher seeks to find solutions for 'chemo brain' symptoms and side effects of opioids

With a pair of RO1 grants from the National Institutes of Health, pain researcher Daniela Salvemini, Ph.D., will embark on two new research projects, studying chemotherapy-induced cognitive impairment, or "chemo brain," symptoms and unwanted side effects of opioids.

23 Oct 2018

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck, known as MSD outside the United States and Canada, today announced the first presentation of preliminary data from a Phase 1 clinical trial evaluating MK-1454, an investigational STING (stimulator of interferon genes) agonist, as monotherapy and in combination with KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy, in patients with advanced solid tumors or lymphomas.

22 Oct 2018

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck, known as MSD outside the United States and Canada, today announced the first presentation of results from an interim analysis of KEYNOTE-057, a Phase 2 trial evaluating KEYTRUDA, Merck's anti-PD-1 therapy, for previously treated patients with high-risk non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ or CIS plus papillary disease (Cohort A).

22 Oct 2018

Report predicts life expectancy in 2040, Spain comes out on top

A new report from the Institute for Health Metrics and Evaluation (IHME) states that people born and living in Spain, Japan, and China are likely to live longer than those born and living in the United States.

18 Oct 2018

Infectious Diseases News and Research

Rising temperatures may boost number of cases of Lyme disease, finds study

University of Missouri receives NIH grant for continued operation of NSRRC

Scientists pinpoint TIM-3 protein as next potential target for immunotherapy treatments

Research reveals high stability of hepatitis B viruses

New resource outlines neurologic effects and treatment options for biologic, chemical attacks

The Lancet Infectious Diseases journal publishes clinical trial results for Shionogi’s cefiderocol

Scientists determine normal function of gene associated with ALS and FTD

High-dose influenza vaccine associated fewer hospitalizations in dialysis patients

HPTN 075 study shows high risk of HIV infection among MSM and TGW in sub-Saharan Africa

Emergex completes toxicology testing on gold nanoparticle carrier system for vaccine platform

Temperature increases in Zambezi Valley may cause major declines in tsetse populations

Simple technology prevents infectious disease outbreaks in low-resource settings

Gut bacterial community of healthy adults recovers after short-term exposure to broad-spectrum antibiotics

New diagnostic platform simultaneously screens for all known pathogenic bacteria

Scientists develop new class of compounds for treatment of progressive neurodegenerative disorder

Map of human liver cells reveals molecular make-up of individual cells

SLU researcher seeks to find solutions for 'chemo brain' symptoms and side effects of opioids

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Report predicts life expectancy in 2040, Spain comes out on top

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News